Bibliometric analysis of the 50 most cited articles on artificial intelligence for lung cancer imaging

Authors : Mehmet SERİNDERE

Pages : 686-692

Doi:10.32322/jhsm.1294551

View : 63 | Download : 81

Publication Date : 2023-05-31

Article Type : Research Paper

Abstract :Aim: The use of machine learning has now become widespread in lung cancer. However, the research trend is still unclear. This study aimed to analyze the most influential publications on artificial intelligence insert ignore into journalissuearticles values(AI); for lung cancer. Material and Method: A comprehensive PubMed and SCImago Journal and Country Rank insert ignore into journalissuearticles values(SJR); search was performed. The 50 most cited articles were recorded according to the citation numbers, the country and institute of articles, the name and metrics of the publishing journal, the year of publication, and the content of the articles. Results: The citation numbers ranged from 24 to 628. Annual citations per article was between 1.47 and 104.6. The USA was the country with the most publications insert ignore into journalissuearticles values(n=22); followed by The Netherlands insert ignore into journalissuearticles values(n=9); and Peoples R China insert ignore into journalissuearticles values(n=5);. The journal and institution that highly contributed to the 50 most cited articles were Radiology insert ignore into journalissuearticles values(n=5); and Harvard Medical School insert ignore into journalissuearticles values(n=5);, respectively. Conclusion: The importance of deep learning and AI in lung cancer imaging is increasing day by day. In this study, a detailed bibliometric analysis of the literature on AI in lung cancer imaging was performed. In addition, this bibliometric analysis informs researchers about current influential papers in this field, the characteristics of these studies, and potential future trends in the rapidly evolving field of AI in lung cancer screening.
Keywords : Artificial intelligence, bibliometric analysis, lung cancer